Real World Data Beyond Clinical Trials Clinical trials provide controlled environments with strict monitoring, but real world data captures how GLP-1 medications perform in everyday use
Structure Therapeutics: GSBR-1290 [60] [61] [60] [61] An oral GLP1R agonist, currently being studied in a double-blinded, placebo-controlled Phase 2a clinical trial
What is HRT
Comprehensive Medical Oversight Every patient in our GLP-1 Longevity Program receives: Thorough medical evaluation and baseline testing Personalized dosing protocols based on individual needs Regular monitoring of metabolic markers Ongoing support and dose adjustments as needed Integration with lifestyle optimization strategies Minimal Side Effects with Maximum Benefits Dr
Supplementary Material Acknowledgments The authors would like to thank pharmacists Sarit Carmi and Shira Shalit, from the Division of Clinical Pharmacy, Institute for Drug Research, School of Pharmacy, Hebrew University and Hadassah Medical School, Jerusalem, Israel, for their valuable contribution to the data collection, done while acquiring their PharmD degree